Gladstone Institutional Advisory’s NEOS Enhanced Income 1-3 Month T-Bill ETF CSHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.86M Sell
77,581
-8,419
-10% -$418K 0.14% 162
2025
Q4
$4.28M Buy
86,000
+37,973
+79% +$1.89M 0.16% 140
2025
Q3
$2.39M Sell
48,027
-12,192
-20% -$607K 0.09% 217
2025
Q2
$2.99M Buy
60,219
+3,210
+6% +$159K 0.12% 177
2025
Q1
$2.83M Sell
57,009
-31,296
-35% -$1.56M 0.13% 170
2024
Q4
$4.4M Sell
88,305
-4,367
-5% -$218K 0.2% 113
2024
Q3
$4.62M Buy
92,672
+65,640
+243% +$3.27M 0.23% 108
2024
Q2
$1.35M Buy
+27,032
New +$1.35M 0.07% 273

Other funds holding CSHI

Gladstone Institutional Advisory's CSHI Position: Q1 2026 in Review

Gladstone Institutional Advisory reduced its NEOS Enhanced Income 1-3 Month T-Bill ETF (CSHI) stake by 9.8% in Q1 2026, selling an estimated $418K and leaving 77,581 shares worth $3.86M. The position accounts for 0.14% of the portfolio, ranked #162.

Gladstone Institutional Advisory first reported a position in CSHI in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.62M in Q3 2024. 116 funds tracked by Wall St. Rank hold CSHI as of Q1 2026.

  • Gladstone Institutional Advisory held 77,581 shares of NEOS Enhanced Income 1-3 Month T-Bill ETF worth $3.86M as of Q1 2026.
  • Gladstone Institutional Advisory sold 8,419 NEOS Enhanced Income 1-3 Month T-Bill ETF shares in Q1 2026, an estimated $418K.
  • NEOS Enhanced Income 1-3 Month T-Bill ETF made up 0.14% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #162 holding.
  • Gladstone Institutional Advisory first reported a position in NEOS Enhanced Income 1-3 Month T-Bill ETF in Q2 2024 and has held it in 8 quarters since.
  • Gladstone Institutional Advisory's NEOS Enhanced Income 1-3 Month T-Bill ETF position peaked at $4.62M in Q3 2024.
  • 116 funds tracked by Wall St. Rank held NEOS Enhanced Income 1-3 Month T-Bill ETF as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.